Cargando…

Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways

BACKGROUND: Oridonin is a powerful anticancer compound found in Rabdosia rubescens. However, its potential impact on bladder cancer remains uninvestigated. In this work, we aimed to detect the anticancer effect of oridonin on bladder cancer and explore the molecular mechanisms involved. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Xianping, Zhan, Jiangtao, Zhao, Fan, Zhong, Zunhe, Chen, Mianchuan, Han, Ruifa, Wang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275389/ https://www.ncbi.nlm.nih.gov/pubmed/34285910 http://dx.doi.org/10.1155/2021/4340950

Ejemplares similares

Oridonin inhibits aberrant AKT activation in breast cancer
por: Sun, Bowen, et al.
Publicado: (2018)

Oridonin Delays Aging Through the AKT Signaling Pathway
por: An, Yongpan, et al.
Publicado: (2022)

Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K/AKT/mTOR signaling pathway
por: Zhang, Weijie, et al.
Publicado: (2023)

Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer
por: Lee, Eun Hye, et al.
Publicado: (2020)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
por: Li, Xuguang, et al.
Publicado: (2020)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway
por: Xu, Linhao, et al.
Publicado: (2020)

TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth
por: Gao, Sheng-Lin, et al.
Publicado: (2017)

TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells
por: Wang, Gang, et al.
Publicado: (2020)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Publicado: (2021)

Xyloketal B Suppresses Glioblastoma Cell Proliferation and Migration in Vitro through Inhibiting TRPM7-Regulated PI3K/Akt and MEK/ERK Signaling Pathways
por: Chen, Wen-Liang, et al.
Publicado: (2015)

Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway
por: Cao, Rui, et al.
Publicado: (2016)

Silencing TRPM7 in Mouse Cortical Astrocytes Impairs Cell Proliferation and Migration via ERK and JNK Signaling Pathways
por: Zeng, Zhao, et al.
Publicado: (2015)

Molecular Insight in the Multifunctional Effects of Oridonin
por: Owona, Brice Ayissi, et al.
Publicado: (2015)

Preliminary safety assessment of oridonin in zebrafish
por: Tian, Lili, et al.
Publicado: (2019)

Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019)

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
por: Spirin, Pavel, et al.
Publicado: (2017)

Lidocaine Suppresses Viability and Migration of Human Breast Cancer Cells: TRPM7 as a Target for Some Breast Cancer Cell Lines
por: Liu, Hengrui, et al.
Publicado: (2021)

Knockdown of linc01023 restrains glioma proliferation, migration and invasion by regulating IGF-1R/AKT pathway
por: Yu, Mingjun, et al.
Publicado: (2019)

Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway
por: Zeng, Zhou, et al.
Publicado: (2019)

Oridonin Alleviates IRI-Induced Kidney Injury by Inhibiting Inflammatory Response of Macrophages via AKT-Related Pathways
por: Yan, Ying, et al.
Publicado: (2020)

Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling
por: Wang, Bili, et al.
Publicado: (2019)

TRPM3 Is Expressed in Afferent Bladder Neurons and Is Upregulated during Bladder Inflammation
por: Vanneste, Matthias, et al.
Publicado: (2021)

Solubility and Bioavailability Enhancement of Oridonin: A Review
por: Zhang, Yuanyuan, et al.
Publicado: (2020)

Recent advances in oridonin derivatives with anticancer activity
por: Sobral, Pedro J. M., et al.
Publicado: (2023)

Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways
por: Zhao, Jun, et al.
Publicado: (2022)

TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway
por: Almasi, Shekoufeh, et al.
Publicado: (2019)

Rotenone restrains colon cancer cell viability, motility and epithelial-mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway
por: Xiao, Wenbo, et al.
Publicado: (2020)

Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues
por: Chen, Wei, et al.
Publicado: (2016)

Depletion of Fibroblast Growth Factor 12 Restrains the Viability, Stemness, and Motility of Colorectal Cancer
por: Gao, Xueyuan, et al.
Publicado: (2022)

Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis
por: Schmidt, Christian, et al.
Publicado: (2018)

TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts
por: Zeitlmayr, Sarah, et al.
Publicado: (2022)

HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells
por: Zhang, Huiying, et al.
Publicado: (2012)

Oridonin prevents insulin resistance–mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy
por: Wen, Fangfang, et al.
Publicado: (2019)

MUC21 induces the viability and migration of glioblastoma via the STAT3/AKT pathway
por: Wang, Leibo, et al.
Publicado: (2022)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
por: Zhang, Xiangchao, et al.
Publicado: (2023)

GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways
por: Pi, Jiang, et al.
Publicado: (2017)

Structural modification of oridonin via DAST induced rearrangement
por: Luo, Dong-Dong, et al.
Publicado: (2018)

Oridonin improves the therapeutic effect of lentinan on lung cancer
por: Gui, Yun, et al.
Publicado: (2021)

Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
por: Li, Xiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_52402h6bk7ahmmoai85hstev8r